Please login to the form below

Not currently logged in
Email:
Password:

Grünenthal's Matt Lowe moves agency-side to join Creston Health

Takes up digital role at UK communications group

Creston_Health_Matt_LoweMatt Lowe has left Grünenthal, where he served as a senior marketing manager for its analgesic Palexia, to move agency-side.

He joins UK communications group Creston Health as head of digital and will oversee digital activities at Red Door Communications, Rock Medical Communications, Grapevine and Pan Advertising.

Reporting to the head of Creston Health Catherine Warne, Lowe will play a key role in developing digital health activities amongst the Creston Health companies.

“Having developed a number of successful digital projects, Matt is well versed in the restrictions and challenges that the industry has with online and offline digital tactics,” said Warne.

Lowe spent three years at Grünenthal and before that was at Sanofi, where he started as a GP/hospital sales representative and then moved into roles as a training manager and as a learning and development executive.

Over the past three years, Lowe has been focusing his marketing attention on traditional and innovative digital channels.

“With the restrictions on budgets, diminishing sales forces and the advent of digital as a serious marketing channel within the mix, my aim has been to educate myself and my teams on how to harness digital potential," he said.

5th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics